Old Web
English
Sign In
Acemap
>
Paper
>
扁平上皮非小細胞肺癌の第一選択治療としてのドセタキセル+シスプラチンとペメトレキセド+シスプラチンの無作為化第III相試験:TRAIL試験【Powered by NICT】
扁平上皮非小細胞肺癌の第一選択治療としてのドセタキセル+シスプラチンとペメトレキセド+シスプラチンの無作為化第III相試験:TRAIL試験【Powered by NICT】
2017
Park Cheol-Kyu
Oh In-Jae
Kim Kyu-Sik
Choi Yoo Duk
Jang Tae-Won
Kim Youn-Seup
Lee Kwan Ho
Shin Kyeong-Cheol
Jung Chi-Young
Yang Sei-Hoon
Ryu Jeong Seon
Jang Seung-Hun
Yoo Seung-Soo
Yong Suk-Joong
Lee Kye Young
In Kwang-Ho
Lee Min Ki
Kim Young-Chul
Keywords:
Lung cancer
Oncology
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]